Rx/Reimbursement Adult Incontinence in Australia

Rx/Reimbursement Adult Incontinence in Australia

  • March 2019 •
  • 13 pages •
  • Report ID: 5386098 •
  • Format: PDF
Despite announcements of potential changes to CAPS for adults suffering from incontinence, CAPS remained the scheme through which Australians can apply for government support for adult incontinence products. As a result, rx/reimbursement adult incontinence experienced another year of growth in 2018 as the population continued to age.

Rx/Reimbursement adult incontinence in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2023 illustrate how the market is set to change.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.